Significantly higher and more rapid cytogenetic and molecular responses can be achieved in pre-treated chronic phase CML patients with high doses of Imatinib as induction therapy (800 mg/day, 6 months) - final results of a Phase III CELSG CML11 "ISTAHIT"

Petzer, Andreas L; ...; Bogdanovic, Andrija D; ...; (broj, koautora 20)

Rezultati

eNauka > Rezultati > Significantly higher and more rapid cytogenetic and molecular responses can be achieved in pre-treated chronic phase CML patients with high doses of Imatinib as induction therapy (800 mg/day, 6 months) - final results of a Phase III CELSG CML11 "ISTAHIT"

Naziv:	Significantly higher and more rapid cytogenetic and molecular responses can be achieved in pre-treated chronic phase CML patients with high doses of Imatinib as induction therapy (800 mg/day, 6 months) - final results of a Phase III CELSG CML11 "ISTAHIT"
Autori:	Petzer, Andreas L; ...; Bogdanovic, Andrija D ; ...; (broj, koautora 20)
Godina:	2010
Publikacija:	ONKOLOGIE
ISSN:	0378-584X Onkologie Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 33 str. 83-83
WoS-ID:	000282988400224
URI:	https://enauka.gov.rs/handle/123456789/800788
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.